Evidence map›Paper›PMID 32628356›Full record

ArticleCancer medicine2020

Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real-world multicenter study of a large Chinese cohort from 2006 to 2017.

Chenyan Guo, Xiaoyan Tang, Yan Meng, Ying Zhang, Xuyin Zhang, Jingjing Guo, Xiaohong Lei, Junjun Qiu, Keqin Hua

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Advances in cervical cancer: current insights and future directions.Cancer communications (London, England) · 2025
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chenyan GuoDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-1203-5705
Xiaoyan TangDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Yan MengDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Ying ZhangDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Xuyin ZhangDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Jingjing GuoDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Xiaohong LeiDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Junjun QiuDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Keqin HuaDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
State Key Laboratory of Oncogene and Related Genes · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare survival outcomes of minimally invasive surgery (MIS) and laparotomy in early-stage cervical cancer (CC) patients.

methodsA multicenter retrospective cohort study was conducted with International Federation of Gynecology and Obstetrics (FIGO, 2009) stage IA1 (lymphovascular invasion)-IIA1 CC patients undergoing MIS or laparotomy at four tertiary hospitals from 2006 to 2017. Propensity score matching and weighting and multivariate Cox regression analyses were performed. Survival was compared in various matched cohorts and subgroups.

resultsThree thousand two hundred and fifty-two patients (2439 MIS and 813 laparotomy) were included after matching. (1) The 2- and 5-year recurrence-free survival (RFS) (2-year, hazard ratio [HR], 1.81;95% confidence interval [CI], 1.09-3.0; 5-year, HR, 2.17; 95% CI, 1.21-3.89) or overall survival (OS) (2-year, HR, 1.87; 95% CI, 1.03-3.40; 5-year, HR, 2.57; 95% CI, 1.29-5.10) were significantly worse for MIS in patients with stage I B1, but not the cohort overall (2-year RFS, HR, 1.04; 95% CI, 0.76-1.42; 2-year OS, HR, 0.99; 95% CI, 0.70-1.41; 5-year RFS, HR, 1.12; 95% CI, 0.76-1.65; 5-year OS, HR, 1.20; 95% CI, 0.79-1.83) or other stages (2) In a subgroup analysis, MIS exhibited poorer survival in many population subsets, even in patients with less risk factors, such as patients with squamous cell carcinoma, negative for parametrial involvement, with negative surgical margins, negative for lymph node metastasis, and deep stromal invasion < 2/3. (3) In the cohort treated with (2172, 54%) or without adjuvant treatment (1814, 46%), MIS showed worse RFS than laparotomy in patients treated without adjuvant treatment, whereas no differences in RFS and OS were observed in adjuvant-treatment cohort. (4) Inadequate surgeon proficiency strongly correlated with poor RFS and OS in patients receiving MIS compared with laparotomy.

conclusionsMIS exhibited poorer survival outcomes than laparotomy group in many population subsets, even in low-risk subgroups. Therefore, laparotomy should be the recommended approach for CC patients.

Indexed as

Carcinoma, Squamous CellChinaClinical CompetenceConfidence IntervalsDisease-Free SurvivalFemaleHumansHysterectomyLaparotomyLymphatic MetastasisMiddle AgedMinimally Invasive Surgical ProceduresPropensity ScoreRegression AnalysisRetrospective StudiesSurgeonscervical cancerlaparotomymatchingminimally invasive surgeryradical hysterectomysurvival outcome

Identifiers

PMID32628356
PMCPMC7433827
OpenAlexW3039309157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.